ADVERTISEMENT
Manila Bulletin devider Entertainment devider Celebrities devider Thank Me Later: Donny Pangilinan fronts ADVALight, Belo's newest treatment for young adults' skin concerns

Thank Me Later: Donny Pangilinan fronts ADVALight, Belo's newest treatment for young adults' skin concerns

Published Mar 26, 2023 03:14 am

Donny Pangilinan


There’s always a point in our 20s when we ask the million-dollar question: “When *exactly* do I start aging?” Many sources will give you mixed answers, but Dr. Vicki Belo has a hard and fast answer: “Aging starts at 25 because that’s when your hormones decline.” It’s not a secret that everybody ages. But how to delay aging is also no longer a mystery. This is where *prejuvenation* comes in: the practice of starting anti-aging treatments and skincare at a younger age to prevent signs of aging that tend to catch up on us later in life. So what’s the best way to kickstart your era of prejuvenation? Well, Donny Pangilinan just might have the answer to that.
From the face to the name, Donny needs no further introduction, other than him being the newest face of Belo’s ADVAYouth laser. Successfully reviving classic matinee idol charms and unapologetic sweetness with his longtime leading lady, Donny is the poster boy for living your best life in your ‘20s. But those who lead the same life know that being constantly screen-strapped, beach-bound, and matted with makeup leaves us exposed to UV damage, acne, acne scars, sun spots, and skin texture.
[

Belo ADVALight

](https://belomed.com/services/advalight/) is a skin treatment that’s literally a treat for your skin, thanks to the world’s first and only solid-state yellow laser, made up of two wavelengths: one that heals your scars and hyperpigmentation, as well as zaps the bacteria that causes acne, and another that calms down the oiliness and boosts the collagen that keeps wrinkles and fine lines absent. “Prior to ADVALight, we could only treat acne through medicine and topical solutions,” Dr. Belo shares. “Now, because of this laser machine that shrinks pores, inflammation, and redness, you can have clear and refined skin by using ADVALight every two weeks, for four to six sessions.”
Clearly, ADVALight has all the perks of prejuvenation wrapped up in an easy, hassle-free, and virtually painless 30-minute session you don’t even need to recover from. Suffering from scars that are not on your face? ADVALight can target those on the body, too.
With the help of Donny Pangilinan, Belo invites 20 and 30-something go-getters to keep their eyes on the prize and practice the science of delayed gratification: in a few years, consistent sessions of ADVALight will make you look—and—feel like you’re not a day over 25.
*To book a consultation, visit Belo’s official website*[*here*](https://belomed.com/contact-us/book-an-appointment/)*.*

ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ item.title }}

{{ articles_filter_1564_widget.title }}

{{ item.title }}
.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });
Join Our Newsletters

Sign up by email to receive news.

© 2025 Manila Bulletin The Nation's Leading Newspaper. All Rights Reserved.